‘You could find that each day you looked at those mice, the tumor was decreasing and decreasing, and then just gone.’ Back 2007, experts from both Yale Columbia and University University discovered that triptolide effectively triggers malignancy cell apoptosis, also known as programmed cell death. Numerous other studies through the years have also recognized triptolide as a powerful tumor fighter in a general sense, including as a weapon against aggressive prostate cancers. ‘Triptolide, a diterpenoid isolated from the Chinese herb Tripterygium wilfordii Hook.f, shows antitumor activities in a broad range of great tumors,’ wrote researchers from the University of Texas MD Anderson Tumor Center in a 2006 research on the powerful herb.Besides Allison, Ribas, Yee and Pardoll, team members include: Principals: David Baltimore, Ph.D., California Institute of Technology, Pasadena, Calif. Glenn Dranoff, M.D., Dana-Farber Malignancy Institute, Boston, Mass. Philip D. Greenberg, M.D., Fred Hutchinson Tumor Research Center, Seattle, Clean. Michel Sadelain, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center, New York, N.Y. Ton Schumacher, Ph.D., Netherlands Tumor Institute, Amsterdam, HOLLAND Jedd D. Wolchok, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center, NY, N.Y. Advocates: Robert E. Behrens, REB Investments Inc. Debra Black, Melanoma Study Alliance Roy Doumani, cancer survivor Valerie Guild, Aim at Melanoma Jonathan W. Simons, M.D., Prostate Cancer Foundation Mary Elizabeth Williams, Salon.com..